MYELOMA, PLASMA-CELL

Clinical trials for MYELOMA, PLASMA-CELL explained in plain language.

Never miss a new study

Get alerted when new MYELOMA, PLASMA-CELL trials appear

Sign up with your email to follow new studies for MYELOMA, PLASMA-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy trial aims to train immune cells to hunt blood cancer

Disease control Ongoing

This is an early-stage safety study testing a new type of cell therapy for adults with multiple myeloma that has not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack the cancer, and then i…

Matched conditions: MYELOMA, PLASMA-CELL

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

MYELOMA, PLASMA-CELL

Get alerted when new MYELOMA, PLASMA-CELL trials appear

Gene therapy trial aims to train immune cells to hunt blood cancer